QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
F   16.32 (+0.87%)
GE   79.81 (-0.15%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
F   16.32 (+0.87%)
GE   79.81 (-0.15%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
F   16.32 (+0.87%)
GE   79.81 (-0.15%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
QQQ   333.06 (+0.81%)
AAPL   173.19 (+0.63%)
MSFT   293.47 (+0.53%)
META   180.89 (+0.22%)
GOOGL   122.08 (+0.33%)
AMZN   143.18 (-0.26%)
TSLA   927.96 (+3.10%)
NVDA   190.32 (+1.73%)
NIO   21.30 (+0.90%)
BABA   94.20 (-0.60%)
AMD   101.01 (+0.18%)
MU   64.70 (-0.52%)
T   18.39 (+0.66%)
CGC   3.82 (+15.76%)
F   16.32 (+0.87%)
GE   79.81 (-0.15%)
DIS   124.26 (+2.21%)
AMC   24.21 (-0.94%)
PYPL   101.51 (+0.41%)
PFE   49.75 (-0.72%)
NFLX   249.11 (-0.08%)
NYSE:CL

Colgate-Palmolive - CL Stock Forecast, Price & News

$81.24
+0.95 (+1.18%)
(As of 08/15/2022 12:00 AM ET)
Add
Compare
Today's Range
$80.33
▼
$81.34
50-Day Range
$73.92
▼
$81.97
52-Week Range
$72.20
▼
$85.61
Volume
4.25 million shs
Average Volume
5.17 million shs
Market Capitalization
$67.76 billion
P/E Ratio
35.17
Dividend Yield
2.34%
Price Target
$84.57

Colgate-Palmolive MarketRank™ Forecast

Analyst Rating
Hold
2.20 Rating Score
Upside/​Downside
4.1% Upside
$84.57 Price Target
Short Interest
Healthy
1.65% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-2.16
Upright™ Environmental Score
News Sentiment
0.19mentions of Colgate-Palmolive in the last 14 days
Based on 15 Articles This Week
Insider Trading
Selling Shares
$12.50 M Sold Last Quarter
Proj. Earnings Growth
8.91%
From $3.03 to $3.30 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.17 out of 5 stars

Consumer Staples Sector

73rd out of 150 stocks

Toilet Preparations Industry

5th out of 11 stocks

See Top Rated MarketRank™ Stocks Here
CL stock logo

About Colgate-Palmolive (NYSE:CL) Stock

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CL. JPMorgan Chase & Co. reduced their price target on shares of Colgate-Palmolive from $79.00 to $78.00 in a research report on Thursday, July 21st. StockNews.com raised shares of Colgate-Palmolive from a "hold" rating to a "buy" rating in a research report on Tuesday, August 2nd. UBS Group lifted their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company a "buy" rating in a research report on Monday, August 1st. Atlantic Securities downgraded shares of Colgate-Palmolive from an "overweight" rating to a "neutral" rating and cut their price objective for the stock from $92.00 to $80.00 in a report on Tuesday, May 3rd. Finally, Barclays boosted their price target on shares of Colgate-Palmolive from $71.00 to $74.00 and gave the stock an "equal weight" rating in a report on Tuesday, August 2nd. Twelve equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, Colgate-Palmolive presently has an average rating of "Hold" and a consensus target price of $84.57.

Colgate-Palmolive Stock Up 0.7 %

CL traded up $0.59 during trading on Monday, reaching $80.88. The stock had a trading volume of 42,576 shares, compared to its average volume of 5,177,959. The stock's 50 day moving average is $78.51 and its two-hundred day moving average is $78.16. The company has a current ratio of 1.17, a quick ratio of 0.72 and a debt-to-equity ratio of 14.26. The company has a market capitalization of $67.46 billion, a price-to-earnings ratio of 34.76, a P/E/G ratio of 5.75 and a beta of 0.48. Colgate-Palmolive has a one year low of $72.20 and a one year high of $85.61.

Colgate-Palmolive (NYSE:CL - Get Rating) last posted its quarterly earnings data on Friday, July 29th. The company reported $0.72 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.71 by $0.01. The business had revenue of $4.48 billion during the quarter, compared to the consensus estimate of $4.35 billion. Colgate-Palmolive had a return on equity of 315.10% and a net margin of 10.98%. The firm's quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.80 earnings per share. As a group, analysts expect that Colgate-Palmolive will post 3.03 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, August 15th. Stockholders of record on Thursday, July 21st will be issued a dividend of $0.47 per share. The ex-dividend date of this dividend is Wednesday, July 20th. This represents a $1.88 annualized dividend and a dividend yield of 2.32%. Colgate-Palmolive's payout ratio is presently 81.39%.

Insider Activity at Colgate-Palmolive

In related news, CEO Noel R. Wallace sold 51,665 shares of the stock in a transaction on Thursday, August 4th. The stock was sold at an average price of $81.27, for a total transaction of $4,198,814.55. Following the sale, the chief executive officer now directly owns 221,790 shares of the company's stock, valued at $18,024,873.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 51,665 shares of the firm's stock in a transaction dated Thursday, August 4th. The stock was sold at an average price of $81.27, for a total value of $4,198,814.55. Following the transaction, the chief executive officer now directly owns 221,790 shares of the company's stock, valued at $18,024,873.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the firm's stock in a transaction dated Monday, June 6th. The stock was sold at an average price of $79.34, for a total value of $3,967,000.00. Following the completion of the transaction, the chief executive officer now directly owns 221,790 shares in the company, valued at $17,596,818.60. The disclosure for this sale can be found here. Insiders have sold 126,368 shares of company stock valued at $10,172,933 over the last ninety days. Insiders own 0.31% of the company's stock.

Receive CL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.

CL Stock News Headlines

August 1, 2022 | marketbeat.com
The Colgate-Palmolive Growth Outlook Brightens 
Colgate-Palmolive is a fairly-valued stock in relation to its peers and one that pays a nice 2.4% yield while coming with an outlook for improving margin.
July 25, 2022 | dividendstocks.com
Is Procter & Gamble One of the Best Dividend Stocks of All Time? (CL)
August 10, 2022 | fool.com
Sales Up, Earnings Down: What's Wrong With This Dividend King? - The Motley Fool
August 10, 2022 | americanbankingnews.com
Colgate-Palmolive (NYSE:CL) Upgraded by Wells Fargo & Company to Equal Weight
August 9, 2022 | americanbankingnews.com
Colgate-Palmolive (NYSE:CL) CEO Noel R. Wallace Sells 51,665 Shares
August 9, 2022 | americanbankingnews.com
Colgate-Palmolive (NYSE:CL) Insider Jennifer Daniels Sells 24,703 Shares of Stock
August 6, 2022 | americanbankingnews.com
Colgate-Palmolive (NYSE:CL) Lifted to Buy at StockNews.com
August 6, 2022 | americanbankingnews.com
Colgate-Palmolive (NYSE:CL) Given New $74.00 Price Target at Barclays
August 5, 2022 | americanbankingnews.com
Jefferies Financial Group Weighs in on Colgate-Palmolive's Q4 2022 Earnings (NYSE:CL)
August 4, 2022 | americanbankingnews.com
Colgate-Palmolive (NYSE:CL) Lifted to "Equal Weight" at Wells Fargo & Company
August 4, 2022 | americanbankingnews.com
Barclays Boosts Colgate-Palmolive (NYSE:CL) Price Target to $74.00
August 4, 2022 | americanbankingnews.com
Colgate-Palmolive (NYSE:CL) PT Raised to $90.00
August 4, 2022 | americanbankingnews.com
FY2023 EPS Estimates for Colgate-Palmolive (NYSE:CL) Cut by Analyst
August 1, 2022 | benzinga.com
Colgate-Palmolive shares are trading higher after Wells Fargo upgraded the stock from Underweight to Equa - Benzinga
August 1, 2022 | moodys.com
Research: Rating Action: Moody's rates Colgate bonds Aa3; outlook stable - Moody's
August 1, 2022 | streetinsider.com
UPDATE: Wells Fargo Upgrades Colgate-Palmolive Company (CL) to Equal Weight - StreetInsider.com
August 1, 2022 | marketwatch.com
Colgate-Palmolive to Buy Three Dry Pet-Food Plants for $700 Million >CL - MarketWatch
August 1, 2022 | seekingalpha.com
Colgate-Palmolive invests $700M to bolster pet food business (NYSE:CL) - Seeking Alpha
August 1, 2022 | businesswire.com
Colgate-Palmolive Company Invests in Growth of its Hill's Pet Nutrition Business with Agreement to Buy Three Manufacturing Plants from Red Collar Pet Foods - Business Wire
August 1, 2022 | finance.yahoo.com
Colgate-Palmolive to acquire three Red Collar pet food manufacturing plants for $700 million
July 31, 2022 | greenwichtime.com
Colgate-Palmolive: Q2 Earnings Snapshot - Greenwich Time
July 29, 2022 | investing.com
Colgate-Palmolive Tops Q2 EPS by 1c; Raises Sales Outlook By Investing.com - Investing.com
July 29, 2022 | finance.yahoo.com
Colgate (CL) Earnings & Sales Beat in Q2 on Pricing Plans
July 29, 2022 | businesswire.com
Colgate-Palmolive Company Names Stephan Habif Chief Technology Officer - Business Wire
July 28, 2022 | benzinga.com
A Preview Of Colgate-Palmolive's Earnings - Benzinga
See More Headlines
Receive CL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.

CL Company Calendar

Ex-Dividend for 8/15 Dividend
7/20/2022
Last Earnings
7/29/2022
Today
8/15/2022
Dividend Payable
8/15/2022
Next Earnings (Estimated)
11/04/2022
Fiscal Year End
12/31/2022
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Toilet preparations
Sub-Industry
Household Products
Sector
Consumer Staples
Current Symbol
NYSE:CL
CUSIP
19416210
CIK
21665
Web
www.colgatepalmolive.com
Phone
(212) 310-2000
Fax
212-310-3284
Employees
33,800
Year Founded
1806

Price Target and Rating

Average Stock Price Forecast
$84.57
High Stock Price Forecast
$95.00
Low Stock Price Forecast
$74.00
Forecasted Upside/Downside
+4.1%
Consensus Rating
Hold
Rating Score (0-4)
2.20
Research Coverage
15 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$2.31
Trailing P/E Ratio
35.17
Forward P/E Ratio
26.81
P/E Growth
5.75
Net Income
$2.17 billion
Net Margins
10.98%
Pretax Margin
15.89%
Return on Equity
315.10%
Return on Assets
16.60%

Debt

Debt-to-Equity Ratio
14.26
Current Ratio
1.17
Quick Ratio
0.72

Sales & Book Value

Annual Sales
$17.42 billion
Price / Sales
3.89
Cash Flow
$4.62 per share
Price / Cash Flow
17.60
Book Value
$1.15 per share
Price / Book
70.64

Miscellaneous

Outstanding Shares
834,120,000
Free Float
831,534,000
Market Cap
$67.76 billion
Optionable
Optionable
Beta
0.48

Social Links


Key Executives

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













CL Stock - Frequently Asked Questions

Should I buy or sell Colgate-Palmolive stock right now?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There are currently 12 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CL, but not buy additional shares or sell existing shares.
View CL analyst ratings or view top-rated stocks.

What is Colgate-Palmolive's stock price forecast for 2022?

15 equities research analysts have issued twelve-month target prices for Colgate-Palmolive's shares. Their CL share price forecasts range from $74.00 to $95.00. On average, they predict the company's share price to reach $84.57 in the next year. This suggests a possible upside of 4.1% from the stock's current price.
View analysts price targets for CL or view top-rated stocks among Wall Street analysts.

How have CL shares performed in 2022?

Colgate-Palmolive's stock was trading at $85.34 at the beginning of the year. Since then, CL shares have decreased by 4.8% and is now trading at $81.24.
View the best growth stocks for 2022 here.

Are investors shorting Colgate-Palmolive?

Colgate-Palmolive saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 13,810,000 shares, an increase of 37.3% from the July 15th total of 10,060,000 shares. Based on an average daily volume of 4,670,000 shares, the short-interest ratio is presently 3.0 days. Approximately 1.7% of the shares of the company are sold short.
View Colgate-Palmolive's Short Interest.

When is Colgate-Palmolive's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our CL earnings forecast.

How were Colgate-Palmolive's earnings last quarter?

Colgate-Palmolive (NYSE:CL) posted its quarterly earnings results on Friday, July, 29th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.01. The firm had revenue of $4.48 billion for the quarter, compared to analyst estimates of $4.35 billion. Colgate-Palmolive had a trailing twelve-month return on equity of 315.10% and a net margin of 10.98%. The company's revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the previous year, the company earned $0.80 earnings per share.
Read the conference call transcript.

How often does Colgate-Palmolive pay dividends? What is the dividend yield for Colgate-Palmolive?

Colgate-Palmolive announced a quarterly dividend on Thursday, June 9th. Stockholders of record on Thursday, July 21st will be given a dividend of $0.47 per share on Monday, August 15th. This represents a $1.88 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend is Wednesday, July 20th.
Read our dividend analysis for CL.

Is Colgate-Palmolive a good dividend stock?

Colgate-Palmolive (NYSE:CL) pays an annual dividend of $1.88 per share and currently has a dividend yield of 2.34%. The company has been increasing its dividend for 59 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 81.39%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, CL will have a dividend payout ratio of 56.97% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CL.

How will Colgate-Palmolive's stock buyback program work?

Colgate-Palmolive announced that its Board of Directors has authorized a share repurchase program on Thursday, March 10th 2022, which permits the company to buyback $5,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 8.1% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's leadership believes its stock is undervalued.

What guidance has Colgate-Palmolive issued on next quarter's earnings?

Colgate-Palmolive issued an update on its FY 2022 earnings guidance on Friday, August, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $18.12 billion-$18.12 billion, compared to the consensus revenue estimate of $17.81 billion.

What is Noel Wallace's approval rating as Colgate-Palmolive's CEO?

195 employees have rated Colgate-Palmolive Chief Executive Officer Noel Wallace on Glassdoor.com. Noel Wallace has an approval rating of 95% among the company's employees. This puts Noel Wallace in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Colgate-Palmolive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Colgate-Palmolive investors own include Johnson & Johnson (JNJ), Procter & Gamble (PG), AT&T (T), AbbVie (ABBV), PepsiCo (PEP), Verizon Communications (VZ), Coca-Cola (KO), Intel (INTC), McDonald's (MCD) and Walt Disney (DIS).

What is Colgate-Palmolive's stock symbol?

Colgate-Palmolive trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Who are Colgate-Palmolive's major shareholders?

Colgate-Palmolive's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (3.66%), Deutsche Bank AG (1.25%), Northern Trust Corp (1.24%), Wells Fargo & Company MN (0.95%), GUARDCAP ASSET MANAGEMENT Ltd (0.78%) and California Public Employees Retirement System (0.71%). Insiders that own company stock include Daniel B Marsili, Helene D Gayle, Henning I Jakobsen, Ian M Cook, Ian M Cook, Jennifer Daniels, John J Huston, John P Bilbrey, John T Cahill, John W Kooyman, Lorrie M Norrington, Michael B Polk, Noel R Wallace, Panagiotis Tsourapas, Patricia Verduin, Philip G Shotts, Prabha Parameswaran, Sally Massey and Stephen I Sadove.
View institutional ownership trends.

How do I buy shares of Colgate-Palmolive?

Shares of CL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Colgate-Palmolive's stock price today?

One share of CL stock can currently be purchased for approximately $81.24.

How much money does Colgate-Palmolive make?

Colgate-Palmolive (NYSE:CL) has a market capitalization of $67.76 billion and generates $17.42 billion in revenue each year. The company earns $2.17 billion in net income (profit) each year or $2.31 on an earnings per share basis.

How many employees does Colgate-Palmolive have?

The company employs 33,800 workers across the globe.

Does Colgate-Palmolive have any subsidiaries?
The following companies are subsidiares of Colgate-Palmolive: 887357 Ontario Inc., COLGALIVE S.A., CP GABA GmbH, CP International Holding C.V., CP West East Investment Limited, Cleaning Dimensions Inc., Colgate (BVI) Limited, Colgate (Guangzhou) Company Limited, Colgate (U.K.) Limited, Colgate Business Services of the Americas S.C., Colgate Flavors and Fragrances Inc., Colgate Global Business Services Private Limited, Colgate Holdings, Colgate Inc., Colgate Oral Pharmaceuticals Inc., Colgate Palmolive Ghana Limited, Colgate Palmolive Holding S.Com.P.A., Colgate Palmolive Nouvelle Caledonie Sarl, Colgate Palmolive Tanzania Limited, Colgate Sanxiao Company Limited, Colgate Venture Company Inc., Colgate-Palmolive (America) Inc., Colgate-Palmolive (Asia) Pte Ltd, Colgate-Palmolive (Blantyre) Limited, Colgate-Palmolive (Brunei) Sdn Bhn, Colgate-Palmolive (Central America) Inc., Colgate-Palmolive (Central America) Inc. y Compañia Limitada, Colgate-Palmolive (Centro America) S.A., Colgate-Palmolive (China) Co. Ltd, Colgate-Palmolive (Costa Rica) S.A., Colgate-Palmolive (Dominica) Inc., Colgate-Palmolive (Dominican Republic) Inc., Colgate-Palmolive (East Africa) Limited, Colgate-Palmolive (Eastern) Pte. Ltd., Colgate-Palmolive (Egypt) S.A.E., Colgate-Palmolive (Far East) Sdn Bhd, Colgate-Palmolive (Fiji) Pte Limited, Colgate-Palmolive (Gabon) S.A., Colgate-Palmolive (Guyana) Ltd., Colgate-Palmolive (H.K.) Limited, Colgate-Palmolive (Hellas) S.A. I.C., Colgate-Palmolive (Hong Kong) Holding Limited, Colgate-Palmolive (Kazakhstan) L.L.P., Colgate-Palmolive (Latvia) Ltd., Colgate-Palmolive (Malaysia) Sdn Bhd, Colgate-Palmolive (Middle East Exports) Ltd., Colgate-Palmolive (Myanmar) Limited, Colgate-Palmolive (New York) Inc., Colgate-Palmolive (Poland) Sp. z o.o., Colgate-Palmolive (Proprietary) Limited, Colgate-Palmolive (Research & Development) Inc., Colgate-Palmolive (Romania) SRL, Colgate-Palmolive (Thailand) Limited, Colgate-Palmolive (UK) Limited, Colgate-Palmolive (Uganda) Limited, Colgate-Palmolive (Vietnam) Ltd., Colgate-Palmolive (Zambia) Inc., Colgate-Palmolive (Zimbabwe) Inc., Colgate-Palmolive A.B., Colgate-Palmolive A/S, Colgate-Palmolive Adria Ltd., Colgate-Palmolive Argentina S.A., Colgate-Palmolive Asia Pacific Limited, Colgate-Palmolive Asia Pacific Treasury Services Limited, Colgate-Palmolive Belgium S.A., Colgate-Palmolive Bolivia Ltda., Colgate-Palmolive Canada Inc., Colgate-Palmolive Caricom Service Co. Inc., Colgate-Palmolive Central European Management Inc., Colgate-Palmolive Chile S.A., Colgate-Palmolive Cia., Colgate-Palmolive Comercial Ltda., Colgate-Palmolive Commercial (Hellas) SP LLC, Colgate-Palmolive Commerciale S.A.S., Colgate-Palmolive Commericale S.r.l., Colgate-Palmolive Compania Anonima, Colgate-Palmolive Company Distr. LLC, Colgate-Palmolive Company GmbH, Colgate-Palmolive Cote d’Ivoire S.A., Colgate-Palmolive Cyprus Limited, Colgate-Palmolive Development Corp., Colgate-Palmolive East West Africa Region (Pty) Ltd, Colgate-Palmolive Enterprises Inc., Colgate-Palmolive Espana S.A., Colgate-Palmolive Europe (Holdings) Sarl, Colgate-Palmolive Europe Sarl, Colgate-Palmolive Finance (UK) plc, Colgate-Palmolive Global Trading Company, Colgate-Palmolive Holding Argentina S.A., Colgate-Palmolive Holding Inc., Colgate-Palmolive Hungary Kft Limited Liability Company, Colgate-Palmolive IHQ Services (Thailand) Limited, Colgate-Palmolive Inc., Colgate-Palmolive Inc. S.A., Colgate-Palmolive Industrial Ltda., Colgate-Palmolive Industriel S.A.S., Colgate-Palmolive International Holding LLC, Colgate-Palmolive International LLC, Colgate-Palmolive Investment Co. Inc., Colgate-Palmolive Investments (BVI) Ltd., Colgate-Palmolive Investments (PNG) Ltd., Colgate-Palmolive Investments (UK) Limited, Colgate-Palmolive Investments Inc., Colgate-Palmolive Israel Ltd., Colgate-Palmolive Italia S.r.l., Colgate-Palmolive JSC, Colgate-Palmolive Lanka (Private) Limited, Colgate-Palmolive Latin America Inc., Colgate-Palmolive Limited, Colgate-Palmolive Manufacturing (Poland) Sp. z o.o., Colgate-Palmolive Marketing Sdn Bhd, Colgate-Palmolive Maroc S.A., Colgate-Palmolive Mocambique Limitada, Colgate-Palmolive NJ Inc., Colgate-Palmolive Nederland B.V., Colgate-Palmolive Norge A/S, Colgate-Palmolive Participacoes e Investimentos Imobiliarios Lda., Colgate-Palmolive Peru S.A., Colgate-Palmolive Philippines Inc., Colgate-Palmolive Pty Ltd, Colgate-Palmolive Retirement Trustee Limited, Colgate-Palmolive S.A. de C.V., Colgate-Palmolive S.p.A., Colgate-Palmolive Senegal S.A., Colgate-Palmolive Services (Hellas) LLC, Colgate-Palmolive Services (Poland) Sp. z o.o., Colgate-Palmolive Services CEW GmbH, Colgate-Palmolive Services S.A., Colgate-Palmolive Slovensko s.r.o., Colgate-Palmolive Support Services, Colgate-Palmolive Temizlik Urunleri Sanayi ve Ticart S.A., Colgate-Palmolive Transnational Inc., Colgate-Palmolive Ukraine LLC, Colgate-Palmolive Unipessoal Lda, Colgate-Palmolive de Paraguay Sociedad Anonima, Colgate-Palmolive de Puerto Rico Inc., Colgate-Palmolive del Ecuador S.A.I.C., Colgate-Palmolive del Peru (Delaware) Inc., Colgate-Palmolive Èeská republika spol. s r.o., Colpal CBS S de R. L. de C. V., Consumer Viewpoint Center Inc., Cotelle S.A., Dimac Development Corp., Dominica Coconut Products Limited, EKIB Inc., ELM Company Limited, Elta MD Holdings Inc., Elta MD Inc., EltaMD, Filorga Americas Inc., Filorga Asia Limited, Filorga Benelux SA, Filorga Cosmetiques Polska, Filorga Middle East DMCC, Filorga Portugal Unipessoal Lda., Filorga RU Limited Liability Company, GABA Europe Holding GmbH, GABA International, GABA International Holding LLC, GABA Schweiz AG, GABA Therwil GmbH, Gamma Development Co. Ltd., Global Trading and Supply LLC, Hamol Ltd., Hello Products, Hello Products LLC, Hill’s Funding Company, Hill’s Pet Nutrition (NZ) Limited, Hill’s Pet Nutrition (Thailand) Co. Ltd., Hill’s Pet Nutrition Asia Limited, Hill’s Pet Nutrition B.V., Hill’s Pet Nutrition Canada Inc., Hill’s Pet Nutrition Denmark ApS, Hill’s Pet Nutrition Espana S.L., Hill’s Pet Nutrition GmbH, Hill’s Pet Nutrition Holding B.V., Hill’s Pet Nutrition Inc., Hill’s Pet Nutrition Indiana Inc., Hill’s Pet Nutrition Italia S.r.l., Hill’s Pet Nutrition Korea Ltd., Hill’s Pet Nutrition Ltd., Hill’s Pet Nutrition Manufacturing B.V., Hill’s Pet Nutrition Manufacturing s.r.o, Hill’s Pet Nutrition Norway AS, Hill’s Pet Nutrition OOO, Hill’s Pet Nutrition Pty. Limited, Hill’s Pet Nutrition S.p.A., Hill’s Pet Nutrition SNC, Hill’s Pet Nutrition Sales Inc., Hill’s Pet Nutrition South Africa Proprietary Limited, Hill’s Pet Nutrition Sweden AB, Hill’s Pet Nutrition Switzerland GmbH, Hill’s Pet Nutrition Taiwan Ltd, Hill’s Pet Nutrition Trading (GZ) Co. Ltd, Hill’s Pet Nutrition de Mexico S.A. de C.V., Hill’s Pet Nutrition de Puerto Rico Inc., Hill’s Pet Nutrition s.r.o., Hill’s Pet Products (Benelux) S.A., Hill’s Pet Products Inc., Hill’s Veterinary Companies of America Inc., Hill’s-Colgate (Japan) Ltd., Hopro Liquidating Corp., Hygiene Systemes et Services SA, IES Enterprises Inc., Inmobiliaria Colpal S. de R.L. de C.V., Inmobiliaria Hills S.A. de C.V., Innovacion Creativa S.A. de C.V., Kolynos Corporation, Laboratoires Filorga Cosmetiques Espana S.L.U., Laboratoires Filorga Cosmetiques Italia S.R.L., Laboratoires Filorga Cosmétiques S.A., Laser Brand Toothpaste, Lournay Sales Inc., Mennen Company, Mennen Interamerica Ltd., Mennen Limited, Mennen South Africa Ltd., Mennen de Chile Ltd., Mennen de Nicargua S.A., Mission Hills Property Corporation, Mission Hills S.A. de C.V., Norwood International Incorporated, Olive Music Publishing Corporation, PCA SKIN, Paramount Research Inc., Penny LLC, Pet Chemicals Inc., Physicians Care Alliance LLC, Productos Halogenados Copalven C.A., Purity Holding Company, Purity Music Publishing Corporation, Refresh Company Limited, Samuel Taylor Holdings B.V., Sanex, Sanxiao Company Limited, Services Development Co. Ltd., Societe Generale de Negoce et de Services (GENESE) S.A., The GDN - The Global Distributive Network SAS, The Lournay Company Inc., The MPDP - The Medical and Pharmaceutic Distributive Platform SAS, The Murphy-Phoenix Company, Tom's of Maine, Tom’s of Maine Holdings Inc., Tom’s of Maine Inc., Veterinary Companies of America Inc., Vipont Pharmaceutical Inc., and XEB Inc..
Read More
When was Colgate-Palmolive founded?

Colgate-Palmolive was founded in 1806.

How can I contact Colgate-Palmolive?

Colgate-Palmolive's mailing address is 300 PARK AVE, NEW YORK NY, 10022. The official website for the company is www.colgatepalmolive.com. The company can be reached via phone at (212) 310-2000, via email at investor_relations@colpal.com, or via fax at 212-310-3284.

This page (NYSE:CL) was last updated on 8/15/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.